In CHEK2-1100delC carriers, the risk of breast cancer did not change in women also carrying P/LP variants in BRCA1, possibly because CHEK2 and BRCA1 may function in the same biological pathway [26,33]. Here, CHEK2 is linked to breast carcinoma.